참고문헌
- Bodogan B, Appelbaum PC : Oxazolidinones : activitiy, mode of action, and mechanism of resistance. Int J Antimicrob Agents 23 : 113-119, 2004 https://doi.org/10.1016/j.ijantimicag.2003.11.003
- Davenport DS, Massanari RM, Pfaller MA, Bale MJ, Streed SA, Hierholzer WJ Jr : Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J Infect Dis 153 : 332-339, 1986 https://doi.org/10.1093/infdis/153.2.332
- Dunne WM Jr, Qureshi H, Pervez H, Nafziger DA : Staphylococcus epidermidis with intermediate resistance to vancomycin : elusive phenotype or laboratory artifact? Clin Infect Dis 33 : 135-137, 2001 https://doi.org/10.1086/320890
- Farber BF, Kaplan MH, Cloqston AG : Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 161 : 37-40, 1990 https://doi.org/10.1093/infdis/161.1.37
- Garrett DO, Jochimsen E, Murfitt K, Hill B, McAllister S, Nelson P, et al : The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol 20 : 167-170, 1999 https://doi.org/10.1086/501605
- Kaatz GW, Seo SM : In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 40 : 799-801, 1996
- Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM : Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 50 : 747-750, 2002 https://doi.org/10.1093/jac/dkf207
- Rayner CR, Baddour LM, Birmingham MC, Norden C, Meagher AK, Schentag JJ : Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 32 : 8-14, 2004 https://doi.org/10.1007/s15010-004-3029-9
- Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PH : Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis 161 : 45-51, 1990 https://doi.org/10.1093/infdis/161.1.45
- Schwalbe RS, Stapleton JT, Gilliqan PH : Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 316 : 927-931, 1987 https://doi.org/10.1056/NEJM198704093161507
- Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, et al : Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 36 : 1020-1027, 1988
- Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP : Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 28 : 2064-2068, 1990
- Wong SS, Ho PL, Woo PC, Yuen KY : Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 29 : 760-767, 1999 https://doi.org/10.1086/520429
- Woodford N, Johnson AP, George RC : Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria. J Antimicrob Chemother 28 : 483-486, 1991 https://doi.org/10.1093/jac/28.4.483